Topical ophthalmic anesthetics are among the most frequently used agents in any ophthalmology clinic. For COA candidates, understanding their mechanism, appropriate clinical applications, storage requirements, and critical safety limitations is essential — both for the exam and for protecting patients in real clinical encounters.
The two primary agents are proparacaine 0.5% and tetracaine 0.5%. While both temporarily abolish corneal sensation by blocking sodium channels in nerve axon membranes, they differ in sting on instillation, allergy profile, storage requirements, and duration. Knowing when and how to use each — and critically, when never to use them — forms a core competency for ophthalmic assistants.
Perhaps the single most important fact about topical anesthetics is one of prohibition: these agents must never be dispensed for a patient to take home. This rule exists because chronic self-administration causes severe, progressive, and sometimes irreversible corneal toxicity. The COA exam tests this concept directly, and it is a patient safety imperative in clinical practice.
Mechanism of Action: Sodium Channel Blockade
Topical anesthetics reversibly block voltage-gated sodium channels in the axon membranes of corneal sensory nerves. The cornea is supplied by the ophthalmic branch (V1) of the trigeminal nerve (CN V), which is densely innervated — the cornea has one of the highest nerve fiber densities of any tissue in the body. By blocking sodium influx, the anesthetic prevents membrane depolarization and therefore prevents action potential propagation. Pain impulses simply cannot travel along the blocked nerve fibers to the brain, resulting in complete corneal anesthesia within 20–30 seconds.
Both proparacaine and tetracaine are ester-type local anesthetics. They are metabolized by plasma pseudocholinesterase (esterases in the tear film and conjunctival tissues) into para-aminobenzoic acid (PABA) derivatives. This metabolic pathway is relevant because patients with pseudocholinesterase deficiency may have prolonged drug effects, and PABA derivatives are responsible for the higher rate of allergic reactions compared to amide-type anesthetics.
Onset
20–30 sec
After instillation of 1 drop
Duration
10–20 min
Adequate for most procedures
Class
Ester
Metabolized to PABA derivatives
Proparacaine vs Tetracaine: Key Differences
While both agents achieve adequate corneal anesthesia, clinicians choose between them based on patient comfort, allergy history, procedure duration, and availability. The COA exam commonly compares the two agents directly.
| Property | Proparacaine 0.5% | Tetracaine 0.5% |
|---|---|---|
| Onset | 20–30 seconds | 20–30 seconds |
| Duration | 10–15 minutes | 15–25 minutes |
| Stinging on instillation | Mild | More pronounced |
| Allergy potential | Low (different PABA structure) | Slightly higher |
| Storage | Refrigerate (2–8°C); degrades at room temp | Room temperature acceptable |
| Common use in US | Most widely used ophthalmic anesthetic | Used in combination products (e.g., Fluress) |
| Preservative | Benzalkonium chloride (BAK) in most formulations | Chlorobutanol in some formulations |
Storage Note: Proparacaine Requires Refrigeration
Proparacaine 0.5% must be stored refrigerated (2–8°C / 36–46°F) and protected from light. At room temperature it undergoes hydrolysis, progressively losing potency. A proparacaine bottle left unrefrigerated for extended periods may appear normal but deliver subtherapeutic anesthesia. Always check the storage requirements and expiration date before clinical use. Tetracaine and combination fluorescein-tetracaine products (Fluress) are generally stable at room temperature.
Clinical Uses of Topical Anesthetics
Topical anesthetics are indicated whenever a procedure requires contact with the cornea or conjunctiva that would otherwise be painful or trigger the blink reflex. The COA exam tests familiarity with which procedures require topical anesthesia and the correct sequence of steps.
Goldmann Applanation Tonometry (GAT)
The most common indication. One drop of proparacaine instilled 30 seconds before the prism contacts the cornea. Often combined with a fluorescein strip or combined fluorescein-anesthetic drop (Fluress). Without anesthesia, the blink reflex makes an accurate IOP reading impossible.
Contact Pachymetry
Ultrasonic pachymetry probes contact the central cornea directly. Topical anesthesia prevents reflex blinking and allows accurate central corneal thickness measurement. Non-contact optical pachymetry (built into many topographers and OCT units) does not require anesthesia.
Gonioscopy
Examination of the anterior chamber angle with a goniolens requires the lens to rest on the anesthetized cornea (with coupling gel). Anesthesia prevents discomfort and allows the patient to maintain steady fixation while the angle is examined, which is especially important during indentation gonioscopy.
Foreign Body Removal
Corneal or conjunctival foreign bodies are removed after topical anesthesia with a sterile needle, spud, or cotton tip under slit lamp magnification. Without anesthesia, the patient's pain and reflex movements make safe removal impossible. Multiple drops may be needed for a prolonged removal procedure (e.g., rust ring removal with a rotating burr).
Subconjunctival Injections
Topical anesthesia is applied before injecting medications (e.g., antibiotics, steroids) into the subconjunctival space with a fine needle. Anesthesia reduces the discomfort of the needle penetration through the conjunctiva. The deeper scleral tissue is not fully anesthetized by topical agents, so patient preparation and patient communication remain important.
Corneal Scraping and Cultures
When a corneal ulcer requires microbiological scraping for culture, topical anesthesia is applied. Note: the anesthetic itself should not be applied directly to the scraping site immediately before sampling because BAK preservative in anesthetic formulations can inhibit bacterial growth in culture media. A brief waiting period or preservative-free anesthetic should be used when possible.
Contraindications and Allergy Considerations
Contraindications
- Known allergy to ester-type local anesthetics or PABA
- Ruptured globe or perforating ocular injury (any contact contraindicated)
- Active corneal infection where culture is needed (BAK may inhibit culture)
- Soft contact lenses in place (remove before instillation; absorb the drug)
Allergy Cross-Reactivity
- Patients allergic to sulfonamides or PABA-containing sunscreens may react to ester anesthetics
- Cross-reactivity between proparacaine and tetracaine exists but is not absolute
- Allergy to amide anesthetics (lidocaine) does NOT predict reaction to ester agents
- Reactions range from mild conjunctival hyperemia to anaphylaxis (rare)
Critical Safety Warning: Toxic Keratopathy
NEVER Dispense Topical Anesthetics for Home Use
This is one of the most critical pharmacological safety concepts on the COA exam and in clinical practice. Under no circumstances should topical anesthetics be dispensed for a patient to use at home for pain relief, regardless of how severe the patient's pain is.
Pathophysiology: Repeated application abolishes corneal sensation chronically. Without pain as a protective signal, the patient rubs the eye vigorously, causing epithelial trauma that goes unfelt. The trophic influence of sensory nerves on epithelial maintenance is also disrupted.
Direct toxicity: The drug itself and its preservatives (BAK) directly damage epithelial cells with repeated exposure, causing epithelial cell death and delayed wound healing.
Consequences: Progressive epithelial defects → stromal ulceration → secondary bacterial infection → corneal perforation → permanent vision loss.
Management of patient pain: Prescribe oral analgesics, cycloplegics for accommodative spasm, bandage contact lenses where appropriate, and treat the underlying condition causing pain.
Patient Instructions After Topical Anesthesia
Do not rub the eye
The anesthetized cornea cannot signal pain from rubbing-induced abrasion. The epithelium is temporarily more vulnerable to mechanical trauma. Instruct patients explicitly before the procedure so they are prepared.
Avoid contact lens insertion until sensation fully returns
Full corneal sensation returns 30–45 minutes after the last drop. Inserting contact lenses before full sensation recovery risks lens-related trauma that cannot be detected through normal pain mechanisms.
Avoid driving immediately after if vision is blurred
Fluorescein instilled with the anesthetic temporarily colors the tear film yellow-orange and may cause transient blur. Remind patients who received fluorescein that vision will return to normal as the dye washes out over 20–30 minutes.
Report persistent discomfort
Once the anesthetic wears off, some discomfort is expected if the procedure involved corneal contact. However, severe or worsening pain, increased redness, or discharge after the procedure should prompt the patient to call the office, as these may indicate a corneal abrasion or other complication.
Documenting Topical Anesthetic Use
Proper documentation of topical anesthetic administration is both a medicolegal requirement and standard clinical practice. The COA is responsible for accurate and complete medication documentation in the patient record.
Documentation Checklist
- Drug name and concentration: e.g., proparacaine 0.5% drops
- Dose: e.g., 1 drop OU
- Time of instillation: important for tracking when sensation will return
- Eye(s) treated: OD (right), OS (left), or OU (both)
- Indication: e.g., prior to GAT, foreign body removal
- Patient's reaction: tolerated well, reported stinging, allergic reaction (rare)
- Lot number and expiration date: for medication traceability
Practice COA Pharmacology Questions
Opterio includes topical anesthetic questions within the COA Pharmacology domain, with AI-powered explanations linking clinical reasoning to exam-style questions.